SKN | Gores Holdings XI Warrant Offers Exposure to a New SPAC Opportunity
Gores Holdings XI, Inc. completed its initial public offering in June 2026, creating a new special purpose acquisition company backed by an affiliate of...
SKN | BirchBioMed Files for Nasdaq Direct Listing With No New Capital Raise
BirchBioMed, a clinical-stage biotechnology company developing treatments for scarring and autoimmune diseases, filed with the U.S. Securities and Exchange Commission on Wednesday to register...
SKN | Metabolic Disorders Biotech VogenX Prices IPO at $13, the High End of the Range
Metabolic disorders biotech VogenX has priced its initial public offering at $13 per share, the high end of its proposed $11 to $13 range,...
SKN | QXO Stock Falls 3.28% as Building Products Distributor Heads Toward Earnings Report
QXO, Inc. shares moved lower in Thursday trading as investors assessed the building products distributor ahead of its upcoming earnings report. The stock was...
SKN | Septerna Shares Surge Nearly 23% as Investors Focus on Oral Small-Molecule Pipeline
Septerna, Inc. (Nasdaq: SEPN) recorded a sharp gain in its latest trading session, closing at $47.76, up $8.91, or 22.93%. The stock continued to...